Ginossar Ventures

Illumex focuses on enhancing structured data for use in generative AI analytics, emphasizing strong governance. The company's platform automates the analysis of metadata to uncover and label data, enriching it with semantic meaning and business context while preserving the integrity of the original data. By providing a generative semantic fabric, Illumex enables organizations to effectively map, interpret, and govern their data and analytics. Its domain-specific AI engine is designed to deliver a reliable and customized language model tailored to the needs of businesses, facilitating improved decision-making and promoting data democratization. Through this approach, Illumex aims to empower organizations to leverage Big Data effectively, enhancing trust and maximizing return on investment.

GlossAI is a company focused on transforming how organizations deliver content to audiences with limited attention spans. By utilizing artificial intelligence, GlossAI's platform automatically generates engaging, bite-sized highlight clips from long-form video content. This technology allows users to efficiently edit and repurpose their pre-recorded content into various formats, such as short videos and blog posts, tailored to different channels and use cases. As a result, organizations can effectively share their messages and connect with their audiences in a more digestible manner.

DeepSurface is a vulnerability management platform that assists cybersecurity teams in automating the analysis and prioritization of vulnerabilities. Developed by cybersecurity experts, the platform is trusted by enterprise companies for its ability to evaluate vulnerabilities within their full context. DeepSurface RiskAnalyzer collects and analyzes over 50 environmental attributes to contextualize individual vulnerabilities and their interconnections, allowing it to predict potential damage an adversary could inflict. This capability enables cybersecurity teams to implement a methodical approach to prioritize and manage vulnerability risks effectively. Headquartered in Portland, Oregon, DeepSurface is a privately held company supported by various venture capital firms.

YonaLink operates a global network of over 30,000 medical centers, focusing on the collection and management of clinical trial data. The company offers a platform that streamlines the migration of clinical research data from electronic health records to electronic data capture systems, ensuring a secure and automated process. By enhancing trial efficiency and data quality, YonaLink alleviates the burden on medical center staff and broadens access to innovative patient care opportunities. Its solutions also aim to accelerate drug and medical device development while promoting patient diversity and enrollment in clinical trials, ultimately enabling healthcare providers and researchers to achieve faster and more accurate data capture.